Academic Journal

Comparing the Vitreous Floaters Functional Questionnaire to the VFQ-25 in Vision Degrading Myodesopsia from Vitreous Floaters.

Λεπτομέρειες βιβλιογραφικής εγγραφής
Τίτλος: Comparing the Vitreous Floaters Functional Questionnaire to the VFQ-25 in Vision Degrading Myodesopsia from Vitreous Floaters.
Συγγραφείς: Sebag J; From VMR Consulting (J.S., J.H.N., K.M.P.Y., A.B.), Huntington Beach, California, USA; Doheny Eye Institute (J.S.), UCLA, Pasadena, California, USA. Electronic address: jsebag@VMRinstitute.com., Nguyen JH; From VMR Consulting (J.S., J.H.N., K.M.P.Y., A.B.), Huntington Beach, California, USA., Yee KMP; From VMR Consulting (J.S., J.H.N., K.M.P.Y., A.B.), Huntington Beach, California, USA., Burchfield A; From VMR Consulting (J.S., J.H.N., K.M.P.Y., A.B.), Huntington Beach, California, USA., Yu F; Center for Community Outreach and Policy (F.Y.), Department of Ophthalmology, Stein and Doheny Eye Institutes, California, USA., Sadun AA; David Geffen School of Medicine (A.A.S.), UCLA, Los Angeles, California, USA.
Πηγή: American journal of ophthalmology [Am J Ophthalmol] 2026 Jun; Vol. 286, pp. 81-89. Date of Electronic Publication: 2026 Feb 24.
Τύπος έκδοσης: Journal Article; Comparative Study; Research Support, Non-U.S. Gov't
Γλώσσα: English
Στοιχεία περιοδικού: Publisher: Elsevier Science Country of Publication: United States NLM ID: 0370500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-1891 (Electronic) Linking ISSN: 00029394 NLM ISO Abbreviation: Am J Ophthalmol Subsets: MEDLINE
Imprint Name(s): Publication: 1999- : New York, NY : Elsevier Science
Original Publication: [Chicago, etc., Ophthalmic Pub. Co., etc.]
Ιατρικοί όροι (MeSH): Vitreous Body*/surgery , Vision Disorders*/physiopathology , Vision Disorders*/diagnosis , Vision Disorders*/etiology , Eye Diseases*/physiopathology , Eye Diseases*/surgery , Eye Diseases*/diagnosis , Sickness Impact Profile*, Visual Acuity/physiology ; Contrast Sensitivity/physiology ; Humans ; Surveys and Questionnaires ; Female ; Vitrectomy ; Male ; Prospective Studies ; Retrospective Studies ; Middle Aged ; ROC Curve ; Ultrasonography ; Adult ; Aged
Περίληψη: Purpose: To compare the Vitreous Floater Functional Questionnaire (VFFQ-23) to the NEI Visual Function Questionnaire (VFQ-25) in patients with vision degrading myodesopsia (VDM) from vitreous floaters. Composite scores for each questionnaire were compared in asymptomatic controls, patients who chose observation (OBS), and those electing vitrectomy. The impact of limited refractive vitrectomy (LRV) on the composite scores of each questionnaire was determined.
Design: A retrospective study comparing questionnaire correlations with management choice (OBS or LRV), and a prospective, non-randomized, interventional case series.
Subjects: 74 subjects were asymptomatic controls; 193 subjects had bilateral floaters: 139 chose OBS, 54 elected LRV surgery.
Methods: Patients complaining of bilateral "floaters" completed the VFFQ-23 and VFQ-25 questionnaires and composite scores were correlated with visual acuity (VA), contrast sensitivity (CS), quantitative ultrasonography (QUS), and management choice (OBS or LRV). LRV was performed in 54 patients, and all tests were repeated at 6, 12, 24, and 36 months post-operatively.
Main Outcome Measures: VFFQ-23 (0 to 100), NEI VFQ-25 (0 to 100), VA (Snellen), CS (Freiburg Acuity Contrast Test), QUS (AU), predictive value, Receiver Operator Characteristic areas under the curve (AUC), decision curve analysis (DCA).
Results: VFFQ-23 correlated with CS (R = -.619; P < .0001) and QUS (R = -.632; P < .0001). VFFQ-23 correctly identified 89% of patients who chose LRV with a positive predictive value of 73.8% for LRV and 95.3% for OBS, while VFQ-25 had a positive predictive value of only 60%; VFFQ-23 AUC = 0.923, VFQ-25 AUC = 0.570. DCA demonstrated a higher net benefit for VFFQ-23 than both "Treat All" and "Treat None" strategies. After LRV, VFFQ-23 improved 72.2% ± 3.2% (P < .001), while VFQ-25 only improved 7.4% ± 1.8%, (P < .001). The difference-in-differences before and after surgery between VFFQ-23 and VFQ-25 was 31.9 ± 12.0 (P < .001).
Conclusions: In patients with vitreous floaters, the VFFQ-23 correlated with CS and QUS. VFFQ-23 was a better predictor of patient management choice (OBS or LRV) and was more sensitive to post-operative improvement than VFQ-25. VFFQ-23 superiority to VFQ-25 was confirmed by DCA. Thus, VFFQ-23 may be more useful in assessing the subjective impact of floaters on visual quality-of-life, in screening/triage, and as an outcome measure of current and future therapies for VDM.
(Copyright © 2026 The Author(s). Published by Elsevier Inc. All rights reserved.)
SCR Disease Name: vitreous floaters
Entry Date(s): Date Created: 20260226 Date Completed: 20260709 Latest Revision: 20260806
Update Code: 20260806
DOI: 10.1016/j.ajo.2026.02.027
PMID: 41748058
Βάση Δεδομένων: MEDLINE
Περιγραφή
ISSN:1879-1891
DOI:10.1016/j.ajo.2026.02.027